Literature DB >> 16025276

Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy.

Wouter V Vogel1, Bart M Wensing, Jorn A van Dalen, Paul F M Krabbe, Frank J A van den Hoogen, Wim J G Oyen.   

Abstract

PURPOSE: Reconstruction parameters are an important factor in PET image quality. In the head and neck area, where the level of photon attenuation is relatively low, standard whole-body reconstruction (SWR) parameters may lead to suboptimal results. The purpose of this study was to evaluate the impact of optimised head and neck reconstruction (OHR) parameters on image quality and diagnostic accuracy, using pathology as the gold standard.
METHODS: SWR parameters consisted of 2 iterations, 8 subsets and a 6-mm Gaussian filter. Predetermined OHR parameters were 4 iterations, 16 subsets and a 5-mm Gaussian filter, generating images with increased spatial and contrast resolution but also with increased noise. SWR- and OHR-based FDG-PET images of 28 patients with malignancies in the head and neck area were evaluated for primary tumour and pathological lymph nodes. Diagnostic accuracy was determined by histopathological verification after lymph node dissection.
RESULTS: Using OHR, sensitivity for detection of a primary tumour increased from 92% to 100%. Eleven additional lymph nodes were visualised in eight patients, resulting in an increased sensitivity for lymph node metastases from 11% to 44%. Specificity decreased from 89% to 74% owing to visualisation of small reactive lymph nodes. In total, using OHR, FDG-PET diagnosis improved in six patients (21%) at the expense of three additional false positives for lymph node metastasis (11%). Primary tumour SUV(max) increased by 42%, indicating enhanced contrast resolution.
CONCLUSION: Image reconstruction adapted to low photon attenuation in the head and neck area may improve image quality and the diagnostic value of FDG-PET, despite a slightly higher false positive rate attributable to the fact that visualisation of FDG accumulation in benign reactive lymph nodes is also enhanced.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025276     DOI: 10.1007/s00259-005-1849-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  21 in total

1.  Calculation of positron range and its effect on the fundamental limit of positron emission tomography system spatial resolution.

Authors:  C S Levin; E J Hoffman
Journal:  Phys Med Biol       Date:  1999-03       Impact factor: 3.609

2.  Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.

Authors:  T Stuckensen; A F Kovács; S Adams; R P Baum
Journal:  J Craniomaxillofac Surg       Date:  2000-12       Impact factor: 2.078

3.  The ECAT EXACT HR: performance of a new high resolution positron scanner.

Authors:  K Wienhard; M Dahlbom; L Eriksson; C Michel; T Bruckbauer; U Pietrzyk; W D Heiss
Journal:  J Comput Assist Tomogr       Date:  1994 Jan-Feb       Impact factor: 1.826

4.  Performance characteristics of a whole-body PET scanner.

Authors:  T R DeGrado; T G Turkington; J J Williams; C W Stearns; J M Hoffman; R E Coleman
Journal:  J Nucl Med       Date:  1994-08       Impact factor: 10.057

5.  Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma.

Authors:  Sandro J Stoeckli; Hans Steinert; Madeleine Pfaltz; Stephan Schmid
Journal:  Head Neck       Date:  2002-04       Impact factor: 3.147

6.  Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients.

Authors:  Heiko Schöder; Yusuf E Erdi; Kenneth Chao; Mithat Gonen; Steven M Larson; Henry W D Yeung
Journal:  J Nucl Med       Date:  2004-04       Impact factor: 10.057

7.  Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.

Authors:  Ronald Boellaard; Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

8.  Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PET.

Authors:  E C S C Etchebehere; H A Macapinlac; M Gonen; K Humm; H W D Yeung; T Akhurst; H I Scher; S M Larson
Journal:  Q J Nucl Med       Date:  2002-06

9.  Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI.

Authors:  J W Braams; J Pruim; N J Freling; P G Nikkels; J L Roodenburg; G Boering; W Vaalburg; A Vermey
Journal:  J Nucl Med       Date:  1995-02       Impact factor: 10.057

10.  Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.

Authors:  C Laubenbacher; D Saumweber; C Wagner-Manslau; R J Kau; M Herz; N Avril; S Ziegler; C Kruschke; W Arnold; M Schwaiger
Journal:  J Nucl Med       Date:  1995-10       Impact factor: 10.057

View more
  6 in total

1.  Segmental acquisition method for stationary objects in (18)F-fluorodeoxyglucose positron emission tomography tests.

Authors:  Keisuke Tsuda; Naoyuki Aikawa; Takayuki Suzuki; Etsuo Moriya; Masayuki Yamaguchi; Hideaki Kitamura; Kouzou Hanai; Izumi O Umeda; Masahiro Fukushi; Noriyuki Moriyama; Hirofumi Fujii
Journal:  Jpn J Radiol       Date:  2010-10-24       Impact factor: 2.374

Review 2.  Use of PET in Head and Neck Cancers.

Authors:  Halil Erdem Özel
Journal:  Turk Arch Otorhinolaryngol       Date:  2015-06-01

3.  Pathology-based validation of FDG PET segmentation tools for volume assessment of lymph node metastases from head and neck cancer.

Authors:  Dominic A X Schinagl; Paul N Span; Frank J A van den Hoogen; Matthias A W Merkx; Piet J Slootweg; Wim J G Oyen; Johannes H A M Kaanders
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-14       Impact factor: 9.236

4.  Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study.

Authors:  Dominic A X Schinagl; Paul N Span; Wim J Oyen; Johannes H A M Kaanders
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-02       Impact factor: 9.236

5.  FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer.

Authors:  Anne I J Arens; Jan W A Postema; Wendy M J Schreurs; Albert Lafeber; Baudewijn W Hendrickx; Wim J G Oyen; Wouter V Vogel
Journal:  PLoS One       Date:  2016-08-24       Impact factor: 3.240

6.  Diagnostic implications of a small-voxel reconstruction for loco-regional lymph node characterization in breast cancer patients using FDG-PET/CT.

Authors:  Daniëlle Koopman; Jorn A van Dalen; Hester Arkies; Ad H J Oostdijk; Anne Brecht Francken; Jos Bart; Cornelis H Slump; Siert Knollema; Pieter L Jager
Journal:  EJNMMI Res       Date:  2018-01-16       Impact factor: 3.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.